Preparation method and application of targeting nano composite material

By loading titanium peroxide on the surface of squid ink nanoparticles and coating hyaluronic acid, the targeted nanocomposite material CINPs@PTC@HA is solved, and the preparation of existing photothermal therapy and chemodynamic therapy is complicated and expensive. Biocompatibility issues have achieved efficient tumor-targeted photothermal therapy.

CN119015255AActive Publication Date: 2024-11-26SOUTH CENTRAL UNIVERSITY FOR NATIONALITIES
View PDF 10 Cites 0 Cited by

Patent Information

Application Number
CN202411172173.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-26
Publication Date
2024-11-26
Estimated Expiration
2044-08-26

AI Technical Summary

Technical Problem

The existing photothermal therapy and chemodynamic therapy have problems such as complex preparation process, expensive materials, poor biocompatibility and insufficient H2O2 concentration in tumor treatment, which limits their therapeutic effect and application scope.

Method used

By preparing natural nanomaterial squid inks (CINPs) with good photothermal effect, titanium peroxide (PTC) is loaded on its surface and coated with hyaluronic acid (HA), the targeted nanocomposite CINPs@PTC@ HA, realizes tumor-targeted photothermal therapy.

Benefits of technology

This method improves the biosafety and degradability of the material, retains excellent photothermal properties, titanium peroxide produces a large amount of reactive oxygen under light, enhances the killing ability of tumor cells, and improves hyaluronic acid coating. Targeting and significantly improving the therapeutic effect.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119015255A_ABST
    Figure CN119015255A_ABST
Patent Text Reader

Abstract

The invention relates to a preparation method of a targeting nano composite material. The targeting nano composite material is prepared by loading titanium peroxide on the surfaces of cuttlefish ink nano particles. A natural nano material cuttlefish ink (CINPs) with a good photo-thermal effect is prepared, titanium peroxide (PTC) capable of additionally generating a large amount of reactive oxygen species (ROS) is loaded on the surface of the CINPs, hyaluronic acid (HA) targeting tumor cells are finally coated, and tumor targeting photo-thermal therapy is achieved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biomedicine technology, and more specifically, to a preparation method of a targeted nanocomposite material and application thereof. Background Art

[0002] In recent years, photothermal therapy (PTT) has become an effective and important method for treating cancer. The main reasons are short treatment time (about a few minutes), low invasiveness, significant efficacy, and few side effects. PTT is a typical photon-triggered treatment method that kills tumor cells through local high temperatures generated by photothermal agents under the excitation of visible light or near-infrared light (600-900nm). Cancer cells are more sensitive to high heat than normal cells. High temperatures can cause irreversible damage to cancer cell membranes and promote protein denaturation. In order to optimize the efficacy of drugs, artificially synthesized nanoparticles have been developed enthusiastically. At the same time, due to the immune escape of tumor cells, other anti-tumor drugs, such as photothermal agents, can not only directly kill tumor cells, but also produce tumor-associated antigens in situ, and are integrated into synthetic nanoparticles to enhance anti-tumor immune responses. Photothermal agents are an important component in PTT applications. They can directly convert light energy into heat energy through non-radiative mechanisms and ablate diseased tissues or cells at high temperatures. Many different types of photothermal agents have been reported, including inorganic nanomaterials and organic nanomaterials. Early research on photothermal agents focused on precious metal nanomaterials, which have good light absorption capabilities and high photothermal conversion efficiency. However, expensive reagents and complex preparation processes are prerequisites for synthesizing nanoparticles, limiting their further application. Cuttlefish ink is a black suspension of natural nanoparticles that is generally believed to protect cuttlefish from predators by spraying and forming a visual smoke screen. Currently, it is widely used in food, art, and medical fields due to its rich nutritional components and various biological properties such as hemostasis, antibacterial, and anti-radiation effects. From a chemical point of view, CINPs are mainly composed of melanin and a small amount of amino acids and monosaccharides, with spherical shape, high dispersibility, and good biocompatibility. On the other hand, due to the photothermal conversion properties of melanin itself, CINPs exhibit excellent photothermal conversion ability and photothermal stability.

[0003] Chemodynamic therapy (CDT) is a new type of tumor treatment technology based on the iron-based Fenton reaction. 2+ , Cu 2+ and Mn 2+etc.) promotes the catalytic reaction with H2O2 to produce highly active and toxic ·OH, which is used for cancer treatment. However, this Fenton or Fenton-like reaction is heavily dependent on the H2O2 concentration, and the H2O2 concentration in TME is not enough to achieve the ideal therapeutic effect. In recent years, peroxotitanium complex (PTC) as a reaction intermediate has been studied by domestic scholars. PTC can exist stably under physiological conditions and can decompose at higher temperatures to produce a large amount of ROS. The superoxide radical anion [O2 - ] is an active oxygen with both anionic and free radical characteristics. The most notable feature of peroxide titanium complexes is that they are derived from O2 2- The color reaction is caused by the electronic transition to the metal cation.

[0004] Hyaluronan is a large polysaccharide composed of repeating disaccharides of glucuronic acid and acetylglucosamine that regulates cell adhesion, migration, and proliferation by interacting with specific cell surface receptors: CD44 and the receptor for HA-mediated motility (RHAMM).

[0005] Therefore, how to combine cuttlefish ink (CINPs), titanium peroxide and hyaluronic acid is the key to the present invention. Summary of the invention

[0006] The present invention provides a method for preparing a targeted nanocomposite material and its application. The method comprises preparing a natural nanomaterial cuttlefish ink (CINPs) with good photothermal effect, loading titanium peroxide (PTC) which can additionally generate a large amount of reactive oxygen species (ROS) on the surface of CINPs, and finally coating hyaluronic acid (HA) to target tumor cells, thereby achieving tumor-targeted photothermal therapy.

[0007] According to one aspect of the present invention, a method for preparing a targeted nanocomposite material is provided. The targeted nanocomposite material comprises titanium peroxide loaded on the surface of squid ink nanoparticles.

[0008] Preferably, based on the above scheme, a method for preparing a targeted nanocomposite material of the present invention comprises the following steps:

[0009] Step 1, obtaining squid ink nanoparticles and dispersing them in ionized water to form a CINPs solution;

[0010] Step 2, polyvinyl pyrrolidone is evenly dispersed in the CINPs solution obtained in step 1, 5% titanium sulfate solution and 10 mol / L hydrogen peroxide solution are added respectively, stirred evenly, and ammonia water is added dropwise to adjust the pH to neutral. After the reaction, the mixture is allowed to stand and then centrifuged to obtain a dispersion of CINPs@PTC nanoparticles.

[0011] Preferably, based on the above scheme, the method further comprises uniformly dispersing the hyaluronic acid solution in the CINPs@PTC solution obtained in step 2, stirring at room temperature, and centrifuging to obtain CINPs@PTC@HA.

[0012] Preferably, based on the above scheme, the mass ratio of the hyaluronic acid solution to CINPs@PTC is 20:1.

[0013] Preferably, based on the above scheme, in step 2, the mass ratio of CINPs to Ti is 1:1.

[0014] Preferably, based on the above scheme, in step 2, the CINPs solution and polyvinyl pyrrolidone are stirred at room temperature for 15 minutes at a speed of 600 r / min.

[0015] The invention also provides a targeted nano composite material of cuttlefish ink loaded with titanium peroxide prepared by the method.

[0016] The present invention also provides a use of the targeted nanocomposite material, namely CINPs@PTC@HA, as a therapeutic drug in biological imaging.

[0017] The present invention also provides a use of the targeted nanocomposite material, namely CINPs@PTC@HA, as a therapeutic drug in tumor treatment.

[0018] The method for preparing a targeted nanocomposite material of the present invention has the following advantages and

[0019] Beneficial effects:

[0020] (1) The cuttlefish ink (CINPs) of the present invention is a naturally formed melanin-rich nanoparticle. Compared with other synthetic photothermal agents, it has higher biosafety, degradability, easy material functionalization, and retains its excellent photothermal performance and photothermal conversion efficiency. At the same time, the smaller size of the nanomaterial can promote high permeability and retention effect of solid tumors.

[0021] (2) The titanium peroxide (PTC) of the present invention is not restricted by these factors and can generate a large amount of active oxygen under light. Combined with photothermal therapy, it has a high killing ability against tumor cells and achieves a good therapeutic effect.

[0022] (3) The present invention coats a layer of hyaluronic acid (HA) on the outer layer of the CINPs@PTC composite nanomaterial, which has the performance of targeted tumor treatment to achieve better therapeutic effects.

[0023] (4) Different from the current materials with only a single property, the CINPs@PTC@HA composite nanomaterial in the present invention not only has excellent PTT performance, but also can produce more ROS in response to light, and has a good tumor treatment effect. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the following briefly introduces the drawings required for describing the embodiments. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without creative work. In the drawings:

[0025] Figure 1 This is a scanning transmission electron micrograph of CINPs@PTC@HA in Example 1 of the present invention.

[0026] Figure 2 This is a photothermal heating effect curve of different concentrations of CINPs@PTC@HA in Example 1 of the present invention.

[0027] Figure 3 This is the ESR spectrum of CINPs@PTC@HA in Example 1 of the present invention.

[0028] Figure 4-1 This is a comparison chart of the cytotoxicity test results of different reagents in Example 1 of the present invention.

[0029] Figure 4-2 This is a graph showing the cell survival rate of the fibroblasts in Example 1 of the present invention.

[0030] Figure 5 This is a fluorescence imaging diagram of the ability of different reagents to produce ROS when co-incubated with 4T1 cells in Example 1 of the present invention.

[0031] Figure 6 This is a live-dead staining data diagram of different reagents co-incubated with 4T1 cells and illuminated in Example 1 of the present invention.

[0032] Figure 7 This is an in vivo imaging diagram of the mouse of the present invention.

[0033] Figure 8 This is a photothermal imaging diagram of the mouse body according to the present invention.

[0034] Fig. 9 This is a diagram showing the changes in tumor volume after treatment with different agents of the present invention.

[0035] Fig.10 This is a graph showing the weight changes of mice after treatment with different agents of the present invention.

[0036] Fig.11Images were taken of tumor volumes after treatment with different agents of the present invention. DETAILED DESCRIPTION

[0037] The specific implementation of the present invention is further described in detail below in conjunction with the accompanying drawings and examples. The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention.

[0038] It should be understood that when used in this specification and the appended claims, the term "comprising" indicates the presence of described features, integers, steps, operations, elements and / or components, but does not exclude the presence or addition of one or more other features, integers, steps, operations, elements, components and / or collections.

[0039] In order to simplify the drawings, only the parts related to the present invention are schematically shown in each figure, and they do not represent the actual structure of the product. In addition, in order to simplify the drawings and facilitate understanding, in some figures, only one of the parts with the same structure or function is schematically drawn or marked. In this article, "one" not only means "only one", but also means "more than one".

[0040] It should be further understood that the term “and / or” used in the specification and appended claims refers to any combination and all possible combinations of one or more of the associated listed items, and includes these combinations.

[0041] In the embodiments shown in the drawings, the indications of directions (such as up, down, left, right, front and back) used to explain the structure and movement of the various components of the present invention are not absolute but relative. These descriptions are appropriate when these components are in the positions shown in the drawings. If the descriptions of the positions of these components change, the indications of these directions also change accordingly.

[0042] In addition, in the description of the present application, the terms "first", "second", etc. are only used to distinguish the description and cannot be understood as indicating or implying relative importance.

[0043] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the specific implementation methods of the present invention will be described below with reference to the accompanying drawings. Obviously, the accompanying drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings and other implementation methods can be obtained based on these drawings without creative work.

[0044] See also Figure 1 , and combined with Figure 2 and Figure 3 As shown, a method for preparing a targeted nanocomposite material of the present invention comprises the following steps:

[0045] Step 1, obtaining ink sacs from fresh cuttlefish, extracting a solution containing CINPs, firstly performing low-speed centrifugation to remove large particles, then performing high-speed centrifugation to obtain CINPs, centrifuging and washing with deionized water to obtain cuttlefish ink nanoparticles, and dispersing the cuttlefish ink nanoparticles in deionized water to form a CINPs solution;

[0046] Step 2, polyvinyl pyrrolidone is uniformly dispersed in the CINPs solution obtained in step 1, and 5% titanium sulfate solution and 10 mol / L hydrogen peroxide solution are added respectively, and ammonia water is dripped into the CINPs dispersion drop by drop under continuous stirring, and the pH is adjusted to neutral, and the reaction is carried out for a certain time. After standing, the unreacted PVP is removed by centrifugation, and the CINPs@PTC nanoparticle dispersion is obtained;

[0047] Step 3, the hyaluronic acid solution is evenly dispersed in the CINPs@PTC solution obtained in step 2, stirred at room temperature for a certain period of time, centrifuged, and washed with deionized water to obtain CINPs@PTC@HA.

[0048] Among them, the mass ratio of CINPs to Ti is equal to 1:1, and the mass ratio of hyaluronic acid solution to CINPs@PTC is 20:1.

[0049] In step 2, ammonia water is added dropwise into the CINPs dispersion under constant stirring, the pH is adjusted to 6.8-7.2, reacted for a certain period of time, allowed to stand and then centrifuged to remove unreacted PVP, washed with deionized water to obtain nanoparticles CINPs@PTC. When adjusting the pH, the ammonia water used needs to be diluted 10 times.

[0050] In the present invention, the squid ink CINPs and polyvinyl pyrrolidone PVP are stirred at room temperature for 15 min at a rotation speed of 600 r / min; after the pH is adjusted to 7, the stirring time is 1 h and the standing time is 2 h.

[0051] In step 3, the specific steps are: adding the hyaluronic acid solution dropwise into the CINPs@PTC solution at a mass ratio of 20:1 under high-speed stirring, stirring at room temperature for 24 hours, centrifuging at 12000, washing with deionized water twice, and redispersing the product in deionized water to obtain a dispersion of CINPs@PTC@HA nanoparticles.

[0052] In order to verify the effect of the present invention, the effect will be explained below with specific embodiments and combined with experimental data tests.

[0053] Example 1

[0054] The method for preparing a targeted nanocomposite material of cuttlefish ink loaded with titanium peroxide of the present invention comprises the following specific steps:

[0055] (1) Preparation of CINPs:

[0056] The purchased fresh squid was dissected and the ink sac was removed. The liquid in the ink sac was extracted to obtain a solution containing CINPs, which was centrifuged at 2000 r / min for 5 min to remove large particles, and then centrifuged at 12000 r / min for 10 min at 4°C to obtain CINPs. Finally, it was washed three times with deionized water (DI water) and suspended in deionized water for later use.

[0057] (2) Preparation of CINPs@PTC:

[0058] Weigh 0.1 g of titanium sulfate and dissolve it in 2.1 mL of sulfuric acid to obtain a 5% titanium sulfate solution. Weigh 0.5 g of polyvinyl pyrrolidone and disperse it in the CINPs prepared above. Stir for 15 min and then add 0.7 mL of 5% titanium sulfate solution. Then add 0.2 mL of 10 mol / L hydrogen peroxide, drop ammonia water, and stir continuously to adjust the pH to about 7. Wash it with deionized water by centrifugation for 3 times, and finally disperse it in deionized water to obtain a CINPs@PTC solution for use.

[0059] (2) Preparation of CINPs@PTC@HA:

[0060] Prepare a 10 mg / mL hyaluronic acid solution and add dropwise to the CINPs@PTC nanoparticle dispersion obtained in (2), stir at room temperature for 24 h, centrifuge at 12000 r / min, wash three times with deionized water, and redisperse the washed nanoparticles in deionized water to obtain a dispersion of the composite nanomaterial CINPs@PTC@HA, which is stored in a refrigerator at 4°C for use.

[0061] The morphology of CINPs@PTC@HA in Example 1 was observed under a scanning transmission electron microscope, and the specific steps were as follows:

[0062] First, the prepared CINPs@PTC@HA liquid sample was dispersed into a uniform suspension by ultrasound, and the powder solution was placed on the copper mesh surface by the drop method and dried; the powder sample was ensured to be evenly distributed on the copper mesh and free of contaminants; the copper mesh was gently blown with an ear-cleaning bulb to ensure that there was no easy-to-fall powder, and a suitable field of view was found under the scanning transmission electron microscope for shooting. The scanning transmission electron microscope results are shown in the attached figure. Figure 1 shown.

[0063] According to the attached Figure 1The results of scanning transmission electron microscopy show that the size of CINPs@PTC@HA nanoparticles is about 200nm, the morphology of CINPs is spherical, and PTC is darker spherical particles attached to the surface of CINPs. A layer of transparent film-like material can be seen on the outside of the nanoparticles wrapped on the surface of CINPs@PTC, proving the successful coating of HA. The overall morphology of CINPs@PTC@HA is relatively uniform and has good dispersion.

[0064] The photothermal heating capacity of CINPs@PTC@HA with different concentrations in Example 1 was tested, and the testing method was as follows:

[0065] First, 1 mL of CINPs@PTC@HA nanoparticle dispersions with different concentrations were taken and illuminated with a laser at 808 nm (2 W / cm 2 ) Use a thermal imager to record the real-time temperature changes of the heating process every 10 seconds. The test results are shown in the attached Figure 2 shown.

[0066] The test results show that the higher the concentration of CINPs@PTC@HA solution, the higher the temperature rise, which has the characteristics of concentration-dependent temperature rise. This shows that CINPs@PTC@HA has a good photothermal effect and shows great potential in tumor photothermal therapy as a natural photothermal agent.

[0067] The CINPs@PTC@HA in Example 1 was subjected to ESR test, and the test method was as follows:

[0068] First, take 30 μL of CINPs@PTC@HA, add 30 μL of DMPO (100 mM methanol as solvent), mix well, and then use a capillary to absorb a certain amount of the mixture. After putting it in a quartz tube, put it into the EPR sample chamber to test superoxide free radicals. The test results are shown in the attached figure. Figure 3 shown.

[0069] according to Figure 3 The test results show that CINPs@PTC@HA nanomaterials have no free radical signal in the dark, but a material vacancy signal peak appears. A free radical signal peak appears after 30 minutes of illumination, and the material vacancy peak also has a vacancy peak and a free radical peak that overlaps. According to the free radical signal peak, it can be determined that the free radical is a superoxide free radical.

[0070] The CINPs@PTC@HA in Example 1 was subjected to a cytotoxicity test, and the test method was as follows:

[0071] 4T1 cells were selected as in vitro research objects, and all cells were cultured in a humidified atmosphere incubator at 37°C and 5% CO2. The experiment was divided into five groups, four of which were illumination groups and one was a non-illumination group. The illumination groups were incubated with 0μg / mL, 25μg / mL, 50μg / mL, 100μg / mL, and 200μg / mL CINPs@HA nanoparticle solution, CINPs@PTC@HA nanoparticle solution, CINPs@PTC nanoparticle solution, and PTC@HA nanoparticle solution in Example 1; the non-illumination group was incubated with 0μg / mL, 25μg / mL, 50μg / mL, 100μg / mL, and 200μg / mL CINPs@PTC@HA nanoparticle solution in 4T1 cells, and then 808nm near-infrared laser (2W / cm 2 ) irradiated 4T1 cells for 5 min. Cytotoxicity was determined using MTT.

[0072] The test results are as attached Figure 4-1 As shown, the test results show that under laser irradiation, CINPs@PTC@HA nanoparticle solution and CINPs@PTC nanoparticle solution can effectively kill 4T1 cells, among which CINPs@PTC@HA nanoparticle solution has the most obvious killing effect.

[0073] In order to further verify the biosafety of the material, mouse embryonic fibroblasts (3T3) were used as normal cells to detect the cytotoxicity of CINPs@PTC@HA. All cells were cultured in a humidified atmosphere incubator at 37°C and 5% CO2. 3T3 cells were incubated with CINPs@PTC@HA nanoparticle dispersions at concentrations of 0 μg / mL, 25 μg / mL, 50 μg / mL, 100 μg / mL, and 200 μg / mL, respectively, and the cytotoxicity was determined using MTT.

[0074] The test results are as follows: Figure 4-2 As shown, the test results showed that the survival rate of 3T3 cells was above 80%, indicating that CINPs@PTC@HA has good biosafety.

[0075] The CINPs@PTC@HA in Example 1 was subjected to intracellular reactive oxygen detection, and the test method was as follows:

[0076] A total of four groups of experiments were set up, one of which was PBS solution without additives, and three of the PBS solutions were added with 200 μg / mL of CINPs and CINPs@PTC@HA nanoparticles, respectively, and incubated with 4T1 cells for 6 hours, stained with 10 μM DCFH-DA, and incubated in the dark for 25 minutes. Then, one group of CINPs@PTC@HA was exposed to light, and then ROS was detected by fluorescence confocal microscopy.

[0077] The test results are as attached Figure 5 As shown, the test results showed that the Control group and the CINPs group had almost no green fluorescence, the CINPs@PTC@HA non-illumination group had a lighter green fluorescence, and the CINPs@PTC@HA illumination group showed stronger green fluorescence, indicating that CINPs@PTC@HA can produce more ROS under near-infrared light irradiation.

[0078] The CINPs@PTC@HA in Example 1 was subjected to a live-dead staining experiment, and the experimental method was as follows:

[0079] Calcein-AM and PI staining techniques were used to observe the cell activity of 4T1 cells. The experiment was divided into four groups: (1) PBS; (2) CINPs; (3) CINPs+Laser; (4) CINPs@PTC@HA; (5) CINPs@PTC@HA+Laser. 4T1 cells were incubated with 200 μg / mL CINPs and CINPs@PTC@HA for 6 h, and then the illumination group was illuminated with 808 nm laser (2 W / cm 2 After incubation for another 6 h, the cells were stained with Calcein-AM and PI in PBS for 30 min, and then washed thoroughly with PBS and observed under a laser confocal microscope.

[0080] The test results are as follows: Figure 6 shown.

[0081] The test results showed that almost all 4T1 cells in the PBS group and CINPs group were stained green, and some cells in the CINPs light group and CINPs@PTC@HA were stained red. In contrast, all cells in the CINPs@PTC@HA light group were stained red, indicating that the cells were dead. The results were consistent with the results of the MTT assay, indicating that the CINPs@PTC@HA nanomaterials have a good ability to kill tumor cells.

[0082] The CINPs@PTC@HA in Example 1 was subjected to an in vivo living imaging experiment, and the experimental method was as follows:

[0083] 4T1 tumor cells (1.2×10 6) were injected subcutaneously into the right hind flank of BALB / c mice to establish a 4T1 tumor transplantation model. When the tumor size reached about 150 mm 3 At 14:1, CINPs@PTC and CINPs@PTC@HA labeled with Cy5 were injected into tumor-bearing mice at a dose of 6 mg / mL via the tail vein (n=3). In vivo imaging was performed using the IVIS imaging system at predetermined time intervals (0, 2, 4, 6, 8, 10, and 12 h) after injection, and the distribution of the drug in the mouse body was evaluated in real time by the changes in fluorescence distribution in the mouse body. 72 hours after intravenous injection, tumor tissues and major organs, including heart, liver, spleen, lung, and kidney, were obtained for stereoscopic fluorescence imaging analysis.

[0084] The test results are as follows: Figure 7 As shown. The test results show that the CINPs@PTC group did not accumulate significantly in the mouse tumor site, while CINPs@PTC@HA accumulated significantly in the mouse tumor site during the entire monitoring period, and concentrated in the tumor site 12 hours after drug injection, indicating that the HA-coated CINPs@PTC nanomaterial has good tumor targeting ability. In addition, fluorescence imaging of in vitro organs showed that 72 hours after the injection of CINPs@PTC@HA drugs with tumor targeting properties, the fluorescence intensity of the tumor site was significantly higher than that of other organ tissues, indicating that CINPs@PTC@HA has excellent tumor targeting ability for solid tumors in vivo.

[0085] The therapeutic effect of CINPs@PTC@HA in Example 1 was tested in a BALB / c mouse subcutaneous tumor model, and the test method was as follows:

[0086] BALB / c mice were divided into five groups: (1) PBS, (2) CINPs@PTC@HA, (3) CINPs@PTC+Laser, (4) CINPs@HA+Laser, and (5) CINPs@PTC@HA+Laser. The nanomedicine was injected into the tail vein and then irradiated with 808 nm laser (2 W / cm 2 ) for 6 minutes of light treatment. During the treatment, a thermal imager was used to monitor the temperature in real time, and the temperature of the mouse tumor site was recorded every 1 minute. The photothermal imaging of the mouse tumor site is shown in the attached figure. Figure 8 shown.

[0087] The test results show that under near-infrared light irradiation, the CINPs@PTC@HA nanomaterial group exhibited a significantly enhanced thermal effect, reaching around 55°C, and had an effective killing ability against tumor cells.

[0088] The mice were weighed and their tumor volumes were measured before light therapy, and every other day after the light therapy. The tumor volume and body weight were measured as shown in the attached Fig. 9 , 10 shown.

[0089] After treatment, the tumor tissue of mice was taken for volume measurement. The test results were as follows: Fig.11 shown.

[0090] The results of the therapeutic effect test showed that CINPs@PTC@HA nanomaterial had the best therapeutic effect and had good biosafety when combined with photothermal therapy.

[0091] Compared with the prior art, the present invention has the following advantages and beneficial effects:

[0092] (1) Among near-infrared light-responsive nanomaterials, inorganic nanomaterials, such as gold nanoparticles and plasma metal clusters, have unclear long-term biocompatibility; and some small molecule photosensitizers, such as indocyanine green (ICG) and chlorin e6 (Ce6), have poor stability and their performance decays significantly after near-infrared light irradiation. Cuttlefish ink nanoparticles (CINPs) are naturally formed melanin-rich nanoparticles. Compared with other synthetic photothermal agents, they have higher biosafety, degradability, and easy material functionalization, and retain their excellent photothermal performance and photothermal conversion efficiency. At the same time, the smaller size of nanomaterials can promote high permeability and retention effects in solid tumors.

[0093] (2) CDT treatment is restricted by many factors such as H2O2 concentration, excessive content of reducing substances, and catalytic activity of metals. Traditional CDT materials such as Fe3O4 have low responsiveness in the micro-acidic environment of tumors, which will restrict the efficiency of OH production. Titanium peroxide (PTC) is not restricted by these factors and can produce a large amount of reactive oxygen under light. Combined with photothermal therapy, it has a high killing ability against tumor cells and achieves good therapeutic effects.

[0094] (3) The present invention coats a layer of hyaluronic acid (HA) on the outer layer of the CINPs@PTC composite nanomaterial, which has the performance of targeted tumor treatment to achieve better therapeutic effects.

[0095] (4) Different from the current materials with only a single property, the CINPs@PTC@HA composite nanomaterial in the present invention not only has excellent PTT performance, but also can produce more ROS in response to light, and has a good tumor treatment effect.

[0096] Finally, the method of the present application is only a preferred implementation scheme and is not intended to limit the protection scope of the present invention. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.

Claims

1. A method for preparing a targeted nanocomposite material, characterized in that: The targeted nanocomposite material comprises titanium peroxide loaded on the surface of squid ink nanoparticles.

2. The method for preparing a targeted nanocomposite material according to claim 1, characterized in that: The following steps are involved: Step 1, obtaining squid ink nanoparticles and dispersing them in deionized water to form a CINPs solution; Step 2, polyvinyl pyrrolidone is evenly dispersed in the CINPs solution obtained in step 1, 5% titanium sulfate solution and 10 mol / L hydrogen peroxide solution are added respectively, stirred evenly, and ammonia water is added dropwise to adjust the pH to neutral. After the reaction, the mixture is allowed to stand and then centrifuged to obtain a dispersion of CINPs@PTC nanoparticles.

3. The method for preparing a targeted nanocomposite material according to claim 2, characterized in that: The method also includes uniformly dispersing the hyaluronic acid solution in the CINPs@PTC solution obtained in step 2, stirring at room temperature, and centrifuging to obtain CINPs@PTC@HA.

4. The method for preparing a targeted nanocomposite material according to claim 3, characterized in that: The mass ratio of the hyaluronic acid solution to CINPs@PTC is 20:

1.

5. The method for preparing a targeted nanocomposite material according to claim 2, characterized in that: In step 2, the mass ratio of CINPs to Ti was 1:

1.

6. The method for preparing a targeted nanocomposite material according to claim 2, characterized in that: In step 2, the CINPs solution and polyvinyl pyrrolidone are stirred at room temperature for 15 min at a speed of 600 r / min.

7. A targeted nanocomposite material of cuttlefish ink loaded with titanium peroxide prepared by the method of claim 3.

8. Use of the targeted nanocomposite material, CINPs@PTC@HA, as a therapeutic drug in bioimaging.

9. Use of the targeted nanocomposite material, i.e. CINPs@PTC@HA, as claimed in claim 7 as a therapeutic drug in tumor treatment.

Citation Information

Patent Citations

  • Solution of particles containing titanium dioxide and titanium peroxide complex and preparation thereof

    CN101448742A

  • Preparation method and application of titanium dioxide-graphene oxide composite material modified by hyaluronic acid of antitumor drug nanometer layer

    CN105194679A

  • Mesoporous titanium peroxide nano-pharmaceutical composition with both lung cancer targeting and enhanced photodynamic therapeutic effects and preparation method thereof

    CN109602917A

  • Preparation method for hyaluronic acid-melanin nanoparticles

    CN110787294A

  • Cuttlefish ink chelated iron nanoparticles as well as preparation method and application thereof

    CN115054688A